TN-BC is characterized by the lack of expression of the estrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor receptor (HER2/ErbB2) and generally includes basal-like and claudin-low subtypes. The gene discussed is ESR1; the disease is breast cancer.